BIOVIE INC. Logo

BIOVIE INC.

Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.

BIVI | US

Overview

Corporate Details

ISIN(s):
US09074F4054
LEI:
Country:
United States of America
Address:
680 W NYE LANE, 89703 CARSON CITY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioVie Inc. is a clinical-stage biopharmaceutical company developing innovative drug therapies for chronic debilitating conditions, with a primary focus on neurological, neurodegenerative, and advanced liver diseases. The company's scientific approach posits that inflammation is a central factor in the progression of these disorders. Its lead therapeutic candidate, bezisterim, is a novel molecule being studied for the treatment of Alzheimer's and Parkinson's disease, aiming to modulate inflammation and enhance brain energy transfer. BioVie is also developing treatments for ascites, a common and life-threatening complication of advanced liver cirrhosis. The company's research incorporates advanced science, including the study of epigenetic mechanisms like DNA methylation to regulate gene expression.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOVIE INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOVIE INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOVIE INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
MiNK Therapeutics, Inc. Logo
Developing allogeneic iNKT cell therapies for cancer and immune-mediated diseases.
United States of America INKT
MIRA PHARMACEUTICALS, INC. Logo
Develops novel ketamine and THC analogs for neurologic and neuropsychiatric disorders.
United States of America MIRA
Mirum Pharmaceuticals, Inc. Logo
Develops and commercializes therapies for rare, debilitating liver diseases in children and adults.
United States of America MIRM
Mithra Pharmaceuticals S.A. Logo
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan 4595
MOA Life Plus Co. Ltd. Logo
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea 142760
Moberg Pharma Logo
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden MOB
Mochida Pharmaceutical Co.,Ltd. Logo
An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.
Japan 4534
Moderna, Inc. Logo
Pioneering mRNA science to create transformative medicines and vaccines for diverse diseases.
United States of America MRNA
MOLECULAR PARTNERS AG Logo
Biopharma firm developing novel DARPin® protein therapies for cancer and serious diseases.
United States of America MOLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.